Related Experiment Video

Updated: Dec 13, 2025

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

P38α MAPK Signaling-A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease

Ursula A Germann¹, John J Alam¹

¹EIP Pharma, Inc., Boston, MA 02116, USA.

International Journal of Molecular Sciences

|August 6, 2020

Summary

Targeting Rab5, a key protein in neurodegenerative diseases like Alzheimer's, shows therapeutic potential. Inhibiting p38-alpha kinase may normalize Rab5 activity, offering new treatment avenues.

Area of Science:

Neuroscience
Cell Biology
Pharmacology

Background:

Neurodegenerative diseases involve protein aggregation and neuroinflammation.
Current treatments targeting single drivers (e.g., amyloid-beta) show limited success.
Rab5, an endosome-associated protein, is implicated in multiple pathogenic pathways.

Purpose of the Study:

To review the role of Rab5 in neurodegenerative disease pathogenesis.
To explore the link between Rab5 and p38-alpha kinase.
To highlight therapeutic opportunities for p38-alpha kinase inhibitors in neurodegenerative diseases.

Main Methods:

Literature review focusing on Rab5 function and its role in neurodegeneration.
Discussion of p38-alpha kinase as a regulator of Rab5.
Summary of evidence supporting p38-alpha kinase inhibitors for therapeutic intervention.

Main Results:

Rab5 is a convergence point for major pathogenic drivers in neurodegenerative diseases.
p38-alpha kinase (p38α) regulates Rab5 activity.
Selective p38α kinase inhibitors can normalize Rab5 activity.

Conclusions:

Modulating Rab5 activity presents a promising therapeutic strategy for neurodegenerative diseases.
p38α kinase inhibitors offer a novel approach to target dysregulated Rab5 in conditions like Alzheimer's disease.

Keywords:

Alzheimer’s Lewy Bodies Rab5 amyloid-β endosome p38 MAPK p38α tau α-synuclein

More Related Videos

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Published on: September 27, 2020

Related Concept Videos

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Rab Cascades

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Articles linked to this work by shared authors, journal, and citation graph.

Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies.

Neurology·2023

Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration.

Nature communications·2022

A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease.

Alzheimer's research & therapy·2021

Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level.

PloS one·2020

Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib).

Molecular cancer therapeutics·2017

Selective Brain-Targeted Antagonism of p38 MAPKα Reduces Hippocampal IL-1β Levels and Improves Morris Water Maze Performance in Aged Rats.

Journal of Alzheimer's disease : JAD·2015

See all related articles